Dr. Mazzoni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Avenue
Cleveland, OH 44193Phone+1 216-445-2025
Education & Training
- Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 2014 - 2017
- Michigan State University College of Osteopathic MedicineClass of 2014
Certifications & Licensure
- OH State License 2020 - 2026
- SC State License 2017 - 2020
- MI State License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study.Majid Jaberi-Douraki, Xuan Xu, Danai Dima, Sikander Ailawadhi, Faiz Anwer
Blood Cancer Journal. 2024-12-20 - Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providers.Carolina Schinke, Binod Dhakal, Sandra Mazzoni, Samantha Shenoy, Sara A Scott
Current Medical Research and Opinion. 2024-10-01 - Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma.Olga Lytvynova, Jenna Jwayyed, Daniel Pastel, Rohan Prasad, Jack Khouri
Antibodies. 2024-09-29
Press Mentions
- Advancing Multiple Myeloma TreatmentMarch 27th, 2025
- Current Approaches to Smoldering Multiple MyelomaJuly 16th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: